General Information of Disease (ID: DISX5NCF)

Disease Name Sinusitis
Disease Class CA0A: Chronic rhinosinusitis
Definition An acute or chronic inflammatory process affecting the mucous membranes of any sinus cavity.
Disease Hierarchy
DIS184KT: Skin inflammation
DISWD40R: Disease
DIS7WBKM: Paranasal sinus disorder
DISX5NCF: Sinusitis
ICD Code
ICD-11
ICD-11: CA0A.Z
ICD-10
ICD-10: J01, J32
Disease Identifiers
MONDO ID
MONDO_0005961
MESH ID
D012852
UMLS CUI
C0037199
MedGen ID
20772
HPO ID
HP:0000246
SNOMED CT ID
36971009

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 18 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Amoxicillin DMUYNEI Approved Small molecular drug [1]
Amphotericin B DMTAJQE Approved Small molecular drug [2]
Ampicillin DMHWE7P Approved Small molecular drug [3]
Bacampicillin DMP54C7 Approved Small molecular drug [4]
Cefuroxime DMSIMD8 Approved Small molecular drug [5]
Clavulanate DM2FGRT Approved Small molecular drug [6]
Cloxacillin DMUTL7O Approved Small molecular drug [7]
Demeclocycline DMZEPFJ Approved Small molecular drug [8]
Doxycycline DM7ICNU Approved Small molecular drug [9]
Ephedrine DMMV0KW Approved Small molecular drug [10]
Fusidic Acid DMWVCF3 Approved Small molecular drug [11]
Meticillin DMIKHN0 Approved Small molecular drug [12]
Minocycline DMVN5OH Approved Small molecular drug [13]
Mometasone DM45OJN Approved Small molecular drug [14]
Oxacillin DMTAFY4 Approved Small molecular drug [15]
Oxytetracycline DMOVH1M Approved Small molecular drug [16]
Pseudoephedrine DMIVJ0D Approved Small molecular drug [10]
Tetracycline DMZA017 Approved Small molecular drug [17]
------------------------------------------------------------------------------------
⏷ Show the Full List of 18 Drug(s)
This Disease is Treated as An Indication in 1 Investigative Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
ZP-011 DMCS2SJ Investigative NA [18]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 6 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
AZGP1 TTUPYLV Limited Biomarker [19]
MET TTNDSF4 Limited Biomarker [19]
CFTR TTRLZHP Strong Biomarker [20]
IL13 TT0GVCH Strong Biomarker [21]
EPX TTCIO0M Definitive Genetic Variation [22]
LTC4S TTW7OTG Definitive Genetic Variation [23]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 DTT(s)
This Disease Is Related to 1 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
SMOX DEOH5V3 Definitive Biomarker [24]
------------------------------------------------------------------------------------
This Disease Is Related to 5 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
PIP OTH719AH Limited Biomarker [19]
PPP1R9B OTDCTHTT Limited Biomarker [19]
RSPH4A OTNDPGEE Disputed Biomarker [25]
CLEC4D OTT7X1UC Strong Altered Expression [26]
AP5B1 OTZGM9QA Definitive Genetic Variation [22]
------------------------------------------------------------------------------------

References

1 Amoxicillin FDA Label
2 Amphotericin B FDA Label
3 Ampicillin FDA Label
4 Bacampicillin FDA Label
5 Cefuroxime FDA Label
6 Clavulanate FDA Label
7 Cloxacillin FDA Label
8 Demeclocycline FDA Label
9 Doxycycline FDA Label
10 Ephedrine FDA Label
11 Facial cellulitis associated with Pseudomonas aeruginosa complicating ophthalmic herpes zoster. Dermatol Online J. 2004 Oct 15;10(2):20.
12 Diagnosis, management and treatment of orbital and periorbital cellulitis in children. Emerg Nurse. 2016 Apr;24(1):30-5; quiz 37.
13 Minocycline FDA Label
14 Mometasone FDA Label
15 Oxacillin FDA Label
16 Oxytetracycline FDA Label
17 Tetracycline FDA Label
18 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
19 Gene expression profiling of nasal polyps associated with chronic sinusitis and aspirin-sensitive asthma.Laryngoscope. 2008 May;118(5):881-9. doi: 10.1097/MLG.0b013e31816b4b6f.
20 Medical reversal of chronic sinusitis in a cystic fibrosis patient with ivacaftor.Int Forum Allergy Rhinol. 2015 Feb;5(2):178-81. doi: 10.1002/alr.21440. Epub 2014 Oct 31.
21 IL-13 Gene Polymorphisms are Associated With Rhinosinusitis and Eosinophilic Inflammation in Aspirin Intolerant Asthma.Allergy Asthma Immunol Res. 2010 Apr;2(2):134-40. doi: 10.4168/aair.2010.2.2.134. Epub 2010 Mar 24.
22 Epigenome-wide association study reveals methylation pathways associated with childhood allergic sensitization.Epigenetics. 2019 May;14(5):445-466. doi: 10.1080/15592294.2019.1590085. Epub 2019 Mar 28.
23 Expression of leukotriene C4 synthase and plasminogen activator inhibitor 1 gene promoter polymorphisms in sinusitis.Am J Rhinol. 2006 Sep-Oct;20(5):545-9. doi: 10.2500/ajr.2006.20.2934.
24 Preclinical therapeutic efficacy of the ciprofloxacin-eluting sinus stent for Pseudomonas aeruginosa sinusitis.Int Forum Allergy Rhinol. 2018 Apr;8(4):482-489. doi: 10.1002/alr.22081. Epub 2018 Jan 15.
25 RSPH3 Mutations Cause Primary Ciliary Dyskinesia with Central-Complex Defects and a Near Absence of Radial Spokes. Am J Hum Genet. 2015 Jul 2;97(1):153-62. doi: 10.1016/j.ajhg.2015.05.004. Epub 2015 Jun 11.
26 C-type lectin receptors mRNA expression in patients with otitis media with effusion.Int J Pediatr Otorhinolaryngol. 2013 Nov;77(11):1846-51. doi: 10.1016/j.ijporl.2013.08.025. Epub 2013 Sep 17.